In colorectal cancer, CD133+/CD44+ colon cancer stem cells have a stronger capacity of bone marrow derived mesenchymal stem cells (BM-MSCs) recruitment compared with CD133-/CD44- colon cancer cells due to IL-8/CXCR2 chemotaxis (80). The gene discussed is PROM1; the disease is colorectal cancer.